TELA Bio, Inc.

NASDAQ:TELA

2.91 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -46.664-44.296-33.276-28.794-22.425-21.092-21.334
Depreciation & Amortization 0.8081.1870.5350.5250.5821.2480.761
Deferred Income Tax 000.01400.0051.223-0.04
Stock Based Compensation 5.0323.9893.6612.0580.4570.2160.197
Change In Working Capital -1.669-5.763-3.469-0.086-6.235-4.4550.075
Accounts Receivables -3.058-2.421-1.5530.149-1.528-0.541-0.578
Inventory -2.718-6.073-5.194-0.62-1.839-4.757-0.127
Accounts Payables 0.011-0.8841.597-2.002-0.7731.914-0.748
Other Working Capital 4.0963.6151.6812.387-2.095-1.0711.528
Other Non Cash Items 1.6364.1352.1031.8412.0932.9363.973
Operating Cash Flow -40.857-40.748-30.432-24.456-25.523-19.924-16.368
Investing Activities:
Investments In Property Plant And Equipment -0.611-1.872-0.627-0.167-2.697-1.562-0.114
Acquisitions Net 000000.0040.013
Purchases Of Investments 0-100-9.28400
Sales Maturities Of Investments 0009.289000
Other Investing Activites 0.012109.289-11.7840.0040.013
Investing Cash Flow -0.599-1.872-0.6279.122-11.981-1.558-0.101
Financing Activities:
Debt Repayment 0100002512.198
Common Stock Issued 46.34134.40.58544.72251.1512.41414.137
Common Stock Repurchased 000.0380000
Dividends Paid 0000000
Other Financing Activities 0.141-3.5480.585-0.31314.3812.41428.868
Financing Cash Flow 46.26740.8520.58544.40965.53227.41426.335
Other Information:
Effect Of Forex Changes On Cash 0.164-0.1440.0110.017-0.00400
Net Change In Cash 4.975-1.912-30.46329.09228.0245.9329.866
Cash At End Of Period 46.99442.01943.93174.39445.30217.27811.346